Baxter International (BAX) Capital Expenditures (2009 - 2026)
Baxter International (BAX) posted quarterly Capital Expenditures of $116.0 million for Q2 2026, down 17.14% year-over-year from $140.0 million in Q2 2025, and down 15.33% quarter-over-quarter from $137.0 million in Q1 2026.
Baxter International (BAX) Capital Expenditures (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Capital Expenditures for 18 consecutive years, with $116.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Capital Expenditures fell 17.14% year-over-year to $116.0 million; the TTM figure through Jun 2026 stood at $504.0 million (down 4.55% YoY), while the FY2025 annual figure was $513.0 million, up 15.02% from the prior year.
- Capital Expenditures slipped to $116.0 million in Q2 2026 per BAX's latest filing, from $137.0 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $165.0 million in Q1 2023 and bottomed at -$61.0 million in Q4 2022.
- Historically, Capital Expenditures has averaged $112.3 million across 5 years, with a median of $133.0 million in 2024.
- Annual changes were most pronounced in 2022 — Capital Expenditures slumped 133.33% — and 2024, when it soared 1016.67%.
- Baxter International's Capital Expenditures stood at -$61.0 million in 2022, then jumped by 250.82% to $92.0 million in 2023, then soared by 43.48% to $132.0 million in 2024, then climbed by 6.06% to $140.0 million in 2025, then dropped by 17.14% to $116.0 million in 2026.
- Business Quant data shows BAX's Capital Expenditures at $116.0 million in Q2 2026, $137.0 million in Q1 2026, and $140.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.49 Bn | 129.28 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.54 Bn | 51.67 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.71 Bn | 34.35 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.80 Bn | 32.33 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.08 Bn | 26.40 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 24.96 Bn | 24.52 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.40 Bn | 15.00 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.82 Bn | 14.68 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Align Technology | 11.48 Bn | 10.37 Bn | 757.43 Mn | 35.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 116.00 Mn |
| Jun 30, 2026 | 116.00 Mn |
| Mar 31, 2026 | 137.00 Mn |
| Mar 31, 2026 | 137.00 Mn |
| Dec 31, 2025 | 140.00 Mn |
| Dec 31, 2025 | 140.00 Mn |
| Sep 30, 2025 | 111.00 Mn |
| Sep 30, 2025 | 111.00 Mn |
| Jun 30, 2025 | 140.00 Mn |
| Jun 30, 2025 | 140.00 Mn |
| Mar 31, 2025 | 122.00 Mn |
| Mar 31, 2025 | 122.00 Mn |
| Dec 31, 2024 | 132.00 Mn |
| Dec 31, 2024 | 132.00 Mn |
| Sep 30, 2024 | 134.00 Mn |
| Sep 30, 2024 | 134.00 Mn |
| Jun 30, 2024 | 70.00 Mn |
| Jun 30, 2024 | 70.00 Mn |
| Mar 31, 2024 | 110.00 Mn |
| Mar 31, 2024 | 110.00 Mn |